We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients (MAPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04754204
Recruitment Status : Completed
First Posted : February 15, 2021
Last Update Posted : February 9, 2022
Sponsor:
Information provided by (Responsible Party):
Zoll Medical Corporation

Brief Summary:
To determine the associations among biometric data, arrhythmias, subject-reported symptoms and subject wellness.

Condition or disease Intervention/treatment
Cardiac Arrhythmia Device: Arrhythmia Management System (AMS)

Detailed Description:
The Arrhythmia Management System records rhythm, heart rate, subject-reported symptoms and multiple parameters that include respiration rate, activity and body posture. These biometric data could provide clinicians better insight into the context of the detected arrhythmias, subject-reported symptoms and wellness status. Hence, the purpose of the study to determine the associations among biometric data, arrhythmias, symptoms and subject wellness.

Layout table for study information
Study Type : Observational
Actual Enrollment : 585 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients Wearing a Novel Device
Actual Study Start Date : December 15, 2020
Actual Primary Completion Date : December 15, 2021
Actual Study Completion Date : December 15, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Arrhythmia

Group/Cohort Intervention/treatment
Patients indicated for Mobile Cardiac Telemetry Monitoring
Patients indicated for Mobile Cardiac Telemetry Monitoring while meeting inclusion/exclusion criteria and enrolled in sequential manner.
Device: Arrhythmia Management System (AMS)
AMS records rhythm, heart rate, subject-reported symptoms, and multiple parameters that include respiration rate, activity and body posture.




Primary Outcome Measures :
  1. Biometric Data Associations to Arrhythmias [ Time Frame: 30 days ]
    MCT Data Sets

  2. Biometric Data Associations to Subject-Reported Symptoms [ Time Frame: 30 days ]
    MCT Data Sets

  3. Biometric Data Associations to Subject Wellness [ Time Frame: 30 days ]
    MCT Data Sets


Secondary Outcome Measures :
  1. Clinician Use of Biometric Data Associations to Arrhythmias [ Time Frame: 30 days ]
    Clinical Case Report Forms

  2. Clinician Use of Biometric Data Associations to Subject-Reported Symptoms [ Time Frame: 30 days ]
    Clinical Case Report Forms

  3. Clinician Use of Biometric Data Associations to Wellness Status of Subject [ Time Frame: 30 days ]
    Clinical Case Report Forms



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult subjects, 21 years or older who:

  1. Require mobile cardiac telemetry monitoring for the detection of non-lethal cardiac arrhythmias
  2. Are without any cardiac implantable electronic devices, including loop recorders
  3. Are without wearable cardioverter defibrillator
  4. Are without Holter monitors, wearable event recorders, and other mobile cardiac telemetry devices at the same time
  5. Are not currently hospitalized
  6. Do not have any skin condition that would prevent them from wearing the AMS device
  7. Are not non-ambulatory
  8. Are not reporting to be pregnant
  9. Are not participating in another clinical study
Criteria

Inclusion Criteria:

  • Subjects who require monitoring for non-lethal cardiac arrhythmias
  • Subjects who have an indication for mobile cardiac telemetry (MCT) monitoring
  • Subjects 21 years of age or older

Exclusion Criteria:

  • Subjects with an implantable cardiac device such as left ventricular assistive device, pacemaker, implanted cardioverter defibrillator (ICD), cardiac resynchronization therapy device, subcutaneous ICD's, pressure monitors and loop monitors
  • Subjects with wearable cardioverter defibrillator, Holter monitors, wearable event recorders, and other mobile cardiac telemetry devices at the same time
  • Subjects currently hospitalized
  • Subjects with a skin condition preventing them from wearing the AMS device
  • Subjects who are non-ambulatory
  • Subjects who are self-reporting to be pregnant
  • Subjects participating in another study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04754204


Locations
Show Show 20 study locations
Sponsors and Collaborators
Zoll Medical Corporation
Investigators
Layout table for investigator information
Study Chair: Ramu Perumal, PhD Zoll Services LLC
Layout table for additonal information
Responsible Party: Zoll Medical Corporation
ClinicalTrials.gov Identifier: NCT04754204    
Other Study ID Numbers: 90D0234
First Posted: February 15, 2021    Key Record Dates
Last Update Posted: February 9, 2022
Last Verified: February 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Zoll Medical Corporation:
cardiac
arrhythmia
Additional relevant MeSH terms:
Layout table for MeSH terms
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes